Liver Biology/Pathobiology

You have full text access to this OnlineOpen article

Integrated approach for the identification of human hepatocyte nuclear factor 4α target genes using protein binding microarrays†

  1. Eugene Bolotin1,
  2. Hailing Liao4,
  3. Tuong Chi Ta2,
  4. Chuhu Yang1,‡,
  5. Wendy Hwang-Verslues3,§,
  6. Jane R. Evans4,
  7. Tao Jiang5,6,
  8. Frances M. Sladek4,6,¶,*

Article first published online: 5 OCT 2009

DOI: 10.1002/hep.23357

Issue

Hepatology

Hepatology

Volume 51, Issue 2, pages 642–653, February 2010

Additional Information

How to Cite

Bolotin, E., Liao, H., Ta, T. C., Yang, C., Hwang-Verslues, W., Evans, J. R., Jiang, T. and Sladek, F. M. (2010), Integrated approach for the identification of human hepatocyte nuclear factor 4α target genes using protein binding microarrays. Hepatology, 51: 642–653. doi: 10.1002/hep.23357

Author Information

  1. 1

    Genetics, Genomics and Bioinformatics Graduate Program, University of California Riverside, Riverside, CA

  2. 2

    Cell, Molecular, and Developmental Biology Graduate Program, University of California Riverside, Riverside, CA

  3. 3

    Environmental Toxicology Graduate Program, University of California Riverside, Riverside, CA

  4. 4

    Department of Cell Biology and Neuroscience, University of California Riverside, Riverside, CA

  5. 5

    Department of Computer Science and Engineering, University of California Riverside, Riverside, CA

  6. 6

    Institute for Integrated Genome Biology (also at UCR)

  1. ‡

    Roche Diagnostics Shanghai Limited, 1045 Central Huaihai Road, Shanghai 200031, China

  2. §

    Genomics Research Center, Academia Sinica, No. 128 Academia Road, Section 2, Nankang District, Taipei 115, Taiwan

  1. fax: 951-827-3087

*Professor of Cell Biology, Department of Cell Biology and Neuroscience, 2115 Biological Sciences, University of California, Riverside, Riverside, CA 92521-0314

  1. †

    Potential conflict of interest: Nothing to report.

  2. fax: 951-827-3087

Publication History

  1. Issue published online: 25 JAN 2010
  2. Article first published online: 5 OCT 2009
  3. Accepted manuscript online: 5 OCT 2009 12:00AM EST
  4. Manuscript Accepted: 27 SEP 2009
  5. Manuscript Received: 26 JUN 2009

Funded by

  • National Institutes of Health [NIH]. Grant Number: DK053892
  • National Science Foundation. Grant Number: IIS-0711129
  • University of California Riverside Institute for Integrative Genome Biology
  • NIH. Grant Number: R21MH087397
  • PhRMA Foundation predoctoral fellowship
  • University of California Toxic Substance Training Grant

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article with Supporting Information (HTML) Get PDF (2240K)

References

  • 1
    Bolotin E, Schnabl J, Sladek F. HNF4A (Homo sapiens). In: Transcription Factor Encyclopedia, http://www.cisreg.ca/tfe; 2009.
  • 2
    Sladek FM, Zhong WM, Lai E, Darnell JE Jr. Liver-enriched transcription factor HNF-4 is a novel member of the steroid hormone receptor superfamily. Genes Dev 1990; 4: 2353–2365.
  • 3
    Hayhurst GP, Lee YH, Lambert G, Ward JM, Gonzalez FJ. Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis. Mol Cell Biol 2001; 21: 1393–1403.
  • 4
    Watt AJ, Garrison WD, Duncan SA. HNF4: a central regulator of hepatocyte differentiation and function. HEPATOLOGY 2003; 37: 1249–1253.
  • 5
    Gupta RK, Kaestner KH. HNF-4alpha: from MODY to late-onset type 2 diabetes. Trends Mol Med 2004; 10: 521–524.
  • 6
    Reijnen MJ, Sladek FM, Bertina RM, Reitsma PH. Disruption of a binding site for hepatocyte nuclear factor 4 results in hemophilia B Leyden. Proc Natl Acad Sci U S A 1992; 89: 6300–6303.
  • 7
    Sladek F, Seidel S. Hepatocyte nuclear factor 4α. In: Burris T, McCabe E, eds. Nuclear Receptors and Genetic Diseases. London: Academic Press; 2001: 309–361.
  • 8
    Ellard S, Colclough K. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity-onset diabetes of the young. Hum Mutat 2006; 27: 854–869.
  • 9
    Gonzalez FJ. Regulation of hepatocyte nuclear factor 4 alpha-mediated transcription. Drug Metab Pharmacokinet 2008; 23: 2–7.
  • 10
    Odom DT, Zizlsperger N, Gordon DB, Bell GW, Rinaldi NJ, Murray HL, et al. Control of pancreas and liver gene expression by HNF transcription factors. Science 2004; 303: 1378–1381.
  • 11
    Odom DT, Dowell RD, Jacobsen ES, Nekludova L, Rolfe PA, Danford TW, et al. Core transcriptional regulatory circuitry in human hepatocytes. Mol Syst Biol 2006; 2: 2006.0017.
  • 12
    Rada-Iglesias A, Wallerman O, Koch C, Ameur A, Enroth S, Clelland G, et al. Binding sites for metabolic disease related transcription factors inferred at base pair resolution by chromatin immunoprecipitation and genomic microarrays. Hum Mol Genet 2005; 14: 3435–3447.
  • 13
    Yuan X, Ta TC, Lin M, Evans JR, Dong Y, Bolotin E, et al. Identification of an endogenous ligand bound to a native orphan nuclear receptor. PLoS ONE 2009; 4: e5609.
  • 14
    Bogan AA, Dallas-Yang Q, Ruse MD, Jr., Maeda Y, Jiang G, Nepomuceno L, et al. Analysis of protein dimerization and ligand binding of orphan receptor HNF4alpha. J Mol Biol 2000; 302: 831–851.
  • 15
    Jiang G, Nepomuceno L, Hopkins K, Sladek FM. Exclusive homodimerization of the orphan receptor hepatocyte nuclear factor 4 defines a new subclass of nuclear receptors. Mol Cell Biol 1995; 15: 5131–5143.
  • 16
    Jiang G, Sladek FM. The DNA binding domain of hepatocyte nuclear factor 4 mediates cooperative, specific binding to DNA and heterodimerization with the retinoid X receptor alpha. J Biol Chem 1997; 272: 1218–1225.
  • 17
    Ellrott K, Yang C, Sladek FM, Jiang T. Identifying transcription factor binding sites through Markov chain optimization. Bioinformatics 2002; 18 (Suppl. 2): S100–S109.
  • 18
    Bulyk ML. Analysis of sequence specificities of DNA-binding proteins with protein binding microarrays. Methods Enzymol 2006; 410: 279–299.
  • 19
    Rada-Iglesias A, Wallerman O, Koch C, Ameur A, Enroth S, Clelland G, et al. Binding sites for metabolic disease related transcription factors inferred at base pair resolution by chromatin immunoprecipitation and genomic microarrays. Hum Mol Genet 2005; 14: 3435–3447.
  • 20
    Neuvial P, Hupe P, Brito I, Liva S, Manie E, Brennetot C, et al. Spatial normalization of array-CGH data. BMC Bioinformatics 2006; 7: 264.
  • 21
    Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003; 19: 185–193.
  • 22
    Karatzoglou A, Smola A, Hornik K, Zeileis A. Kernlab–An S4 Package for Kernel Methods in R. J Stat Softw 2004; 11(9). www.jstatsoft.org.
  • 23
    Hwang-Verslues WW, Sladek FM. Nuclear receptor hepatocyte nuclear factor 4alpha1 competes with oncoprotein c-Myc for control of the p21/WAF1 promoter. Mol Endocrinol 2008; 22: 78–90.
  • 24
    Smyth GK, Speed T. Normalization of cDNA microarray data. Methods 2003; 31: 265–273.
  • 25
    Scacheri PC, Crawford GE, Davis S. Statistics for ChIP-chip and DNase hypersensitivity experiments on NimbleGen arrays. Methods Enzymol 2006; 411: 270–282.
  • 26
    Berger MF, Bulyk ML. Universal protein-binding microarrays for the comprehensive characterization of the DNA-binding specificities of transcription factors. Nat Protoc 2009; 4: 393–411.
  • 27
    Berger MF, Badis G, Gehrke AR, Talukder S, Philippakis AA, Pena-Castillo L, et al. Variation in homeodomain DNA binding revealed by high-resolution analysis of sequence preferences. Cell 2008; 133: 1266–1276.
  • 28
    Badis G, Berger MF, Philippakis AA, Talukder S, Gehrke AR, Jaeger SA, et al. Diversity and complexity in DNA recognition by transcription factors. Science 2009; 324: 1720–1723.
  • 29
    Linnell J, Mott R, Field S, Kwiatkowski DP, Ragoussis J, Udalova IA. Quantitative high-throughput analysis of transcription factor binding specificities. Nucleic Acids Res 2004; 32: e44.
  • 30
    Jiang G, Lee U, Sladek FM. Proposed mechanism for the stabilization of nuclear receptor DNA binding via protein dimerization. Mol Cell Biol 1997; 17: 6546–6554.
  • 31
    Jiang G, Nepomuceno L, Yang Q, Sladek FM. Serine/threonine phosphorylation of orphan receptor hepatocyte nuclear factor 4. Arch Biochem Biophys 1997; 340: 1–9.
  • 32
    Lu P, Rha GB, Melikishvili M, Wu G, Adkins BC, Fried MG, et al. Structural basis of natural promoter recognition by a unique nuclear receptor, HNF4alpha. Diabetes gene product. J Biol Chem 2008; 283: 33685–33697.
  • 33
    Yang C, Bolotin E, Jiang T, Sladek FM, Martinez E. Prevalence of the initiator over the TATA box in human and yeast genes and identification of DNA motifs enriched in human TATA-less core promoters. Gene 2007; 389: 52–65.
  • 34
    Lemaigre F, Zaret KS. Liver development update: new embryo models, cell lineage control, and morphogenesis. Curr Opin Genet Dev 2004; 14: 582–590.
  • 35
    Luebke-Wheeler J, Zhang K, Battle M, Si-Tayeb K, Garrison W, Chhinder S, et al. Hepatocyte nuclear factor 4alpha is implicated in endoplasmic reticulum stress-induced acute phase response by regulating expression of cyclic adenosine monophosphate responsive element binding protein H. HEPATOLOGY 2008; 48: 1242–1250.
  • 36
    Kamiya A, Inoue Y, Gonzalez FJ. Role of the hepatocyte nuclear factor 4alpha in control of the pregnane X receptor during fetal liver development. HEPATOLOGY 2003; 37: 1375–1384.
  • 37
    Ohguchi H, Tanaka T, Uchida A, Magoori K, Kudo H, Kim I, et al. Hepatocyte nuclear factor 4alpha contributes to thyroid hormone homeostasis by cooperatively regulating the type 1 iodothyronine deiodinase gene with GATA4 and Kruppel-like transcription factor 9. Mol Cell Biol 2008; 28: 3917–3931.
  • 38
    Zhang Y, Castellani LW, Sinal CJ, Gonzalez FJ, Edwards PA. Peroxisome proliferator-activated receptor-gamma coactivator 1alpha (PGC-1alpha) regulates triglyceride metabolism by activation of the nuclear receptor FXR. Genes Dev 2004; 18: 157–169.
  • 39
    Tanaka T, Jiang S, Hotta H, Takano K, Iwanari H, Sumi K, et al. Dysregulated expression of P1 and P2 promoter-driven hepatocyte nuclear factor-4alpha in the pathogenesis of human cancer. J Pathol 2006; 208: 662–672.
  • 40
    Yin C, Lin Y, Zhang X, Chen YX, Zeng X, Yue HY, et al. Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4alpha gene. HEPATOLOGY 2008; 48: 1528–1539.
  • 41
    Toyama T, Sasaki Y, Horimoto M, Iyoda K, Yakushijin T, Ohkawa K, et al. Ninjurin1 increases p21 expression and induces cellular senescence in human hepatoma cells. J Hepatol 2004; 41: 637–643.
  • 42
    Caillot F, Daveau R, Daveau M, Lubrano J, Saint-Auret G, Hiron M, et al. Down-regulated expression of the TSAP6 protein in liver is associated with a transition from cirrhosis to hepatocellular carcinoma. Histopathology 2009; 54: 319–327.
  • 43
    Crooks GE, Hon G, Chandonia JM, Brenner SE. WebLogo: a sequence logo generator. Genome Res 2004; 14: 1188–1190.
  • 44
    Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003; 4: P3.
View Full Article with Supporting Information (HTML) Get PDF (2240K)